What is Life Science Reagents Market?
Life science reagent is a part of the pharmaceutical, biotechnology, life science, and health care industries. This industry has applications in the chromatography technique, in vitro diagnostics for chronic and infectious diseases, and monitoring the effectiveness of the therapy, PCR, cell and tissue culture. The life sciences industry is heavily regulated, and R&D teams must adhere to standards and regulations dealing with handling, storage, and environmental conditions in lab facilities. These life science used in the life science industry for the media preparation, separation and purification of molecules, and amplification of biological molecules for the test sample.
Highlights from Life Science Reagents Market Study
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
Key Companies Profiled | BD (Canada), Siemens Healthcare (Germany), Sysmex (Japan), Bio-Rad Laboratories (United States), Danaher (United States), Abbott (United States), PerkinElmer (United States), BioMerieux (France), Meridian Life Science (United States) and Promega (United States) |
The life science reagent market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the expansion of manufacturing plants, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Life Science Reagents market throughout the forecasted period.
BD (Canada), Siemens Healthcare (Germany), Sysmex (Japan), Bio-Rad Laboratories (United States), Danaher (United States), Abbott (United States), PerkinElmer (United States), BioMerieux (France), Meridian Life Science (United States) and Promega (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Roche (Switzerland), Dickinson and Company (United States) and Agilent Technologies (United States). Life Science Reagents Market Segmentation:
Scope | Sub-Segments |
---|
Application / End User | Pharmaceutical, Biotechnology and Others |
Type | Chromatography Reagents, In-vitro Diagnostics Reagents, Polymerase Chain Reaction Reagent Kits and Others |
By Product | Grignard Reagent,Tollens' Reagent,Fehling's Reagent,Collins Reagent,Others |
On the basis of geography, the market of Life Science Reagents has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- COVID-19 Pandemic has Positively Affected the Market
- Chronic Diseases Propelling the Growth of the Life Science Reagents
Market Trend
- Technological Advancements in the Life Sciences Sector and Biotechnology
- Growing Need of Life Science Reagents in the Diagnostics of Diseases and Therapy
Restraints
- High Cost Associated with the Raw Materials
Opportunities
- Life Science Industry Achieving Better Health Outcomes, Domestically and Globally
- Research and Development Creating Numerous Opportunity to the Life Sciences Sector
Challenges
- Rising Expenditure on Life Sciences Research Activities
Market Leaders & Development Strategies
On 26th May 2022, Biosynth Carbosynth announced the acquisition of Aalto Bio Reagents. This acquisition expands the life science platform with the Aalto Bio Reagents and further represents the development in the Biosynth’s development, this broadens its capabilities and offering to the IVD industry.
On 12th May 2022, Beckman Coulter Life Sciences announced a launch of the Aquios Stem system to provide a new solution for stem cell analysis. These Aquios Stem system enables the automation to minimize the hands-on time by 95%, reduces the error-prone steps by 87% and decreases turn around the time. These systems are designed in the field of clinical CD34+ enumeration.
Key Target Audience
Life Science Reagent Manufacturer, Life Science Reagent Supplier and Distributors, Regulatory Bodies, New Entrants, Potential Investors, Research and Development Institutes and Others